Skip to main content

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

Yasmin 21

Covered
  • Active ingredient(s):
  • Manufactured by:
    Bayer Inc. (Bayer)
  • Strength and dosage form:
    Tablet 0.03 mg - 3 mg DIN : 2261723

Yasmin 28

Covered
  • Active ingredient(s):
  • Manufactured by:
    Bayer Inc. (Bayer)
  • Strength and dosage form:
    Tablet 0.03 mg - 3 mg DIN : 2261731

Zamine 21

Covered
  • Active ingredient(s):
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    Tablet 0.03 mg - 3 mg DIN : 2410788

Zamine 28

Covered
  • Active ingredient(s):
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    Tablet 0.03 mg - 3 mg DIN : 2410796

Haloette

Covered
  • Active ingredient(s):
  • Manufactured by:
    Searchlight Pharma Inc. (Search Phm)
  • Strength and dosage form:
    Vaginal ring 2.6 mg -11.4 mg DIN : 2520028

Nuvaring

Covered
  • Active ingredient(s):
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    Vaginal ring 2.6 mg -11.4 mg DIN : 2253186

Alesse 21

Covered
  • Active ingredient(s):
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Tablet 0.020 mg -0.10 mg DIN : 2236974

Alesse 28

Covered
  • Active ingredient(s):
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Tablet 0.020 mg -0.10 mg DIN : 2236975

Alysena 21

Covered

Alysena 28

Covered

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.